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ABSTRACT
Background
Chordomas are malignant bone tumors that are derived from remnant embryonic tissue of the notochord
and are typically found in the axial midline. When they are found outside of the axial skeleton, the
diagnosis can be challenging and elusive. Often, they are overlooked on initial presentation in lieu of other
more common lesions, including cartilage tumors (eg, enchondroma, chondrosarcoma,
osteochondromatosis) due to their overlapping features.
Case Report
A 30-year-old female with a four-year history of intermittent left knee pain presented for initial evaluation.
Physical exam of the knee was unremarkable except for moderate tenderness on palpation. Radiographs
showed a lucent lesion with peripheral sclerosis, eccentrically located within the anteromedial femoral
diaphysis. The patient was subsequently lost to follow-up.
She presented again two years later with similar symptoms. Her physical exam remained unchanged, and
repeat radiographs showed interval growth. She underwent open biopsy of the left distal femur, with
pathology revealing tumor consisting predominantly of epithelioid cells set in an abundant myxoid matrix.
Immunohistology showed cells that stained strongly for EMA, CK19, and brachyury. These findings
support the diagnosis of extra-axial chordoma.
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Discussion
Extra-axial chordomas remain a challenging diagnosis for clinicians due to their extreme rarity and
overlapping features with other more common lesions. They are often misdiagnosed as extraskeletal
myxoid chondrosarcomas or myoepitheliomas. Our patient’s insidious presentation and radiologic
findings present a learning opportunity for clinicians to recognize extra-axial chordomas as a potential
early diagnosis in someone presenting with a long history of intermittent and worsening knee pain.

INTRODUCTION

Chordomas are rare malignant bone tumors that are derived from remnant embryonic tissue of the
notochord. These are low-grade neoplasms that exhibit slow growth but are locally aggressive and
destructive, with a high potential for recurrence1–3. They have an incidence rate of 0.08 cases per 100,000
people and are almost exclusively located in the axial midline, with 32.8% of cases in the mobile spine,
followed by the skull base (32%) and the sacrococcygeal bones (29%)4,5.
A small number of these tumors can also be found outside of the axial skeleton in the nasopharynx,
posterior mediastinum, appendicular skeleton, and soft tissues6. These tumors are referred to as extra-axial
chordomas, and they often share many identical features with their axial counterparts. Histologically, both
types of tumors can have the characteristic physaliferous cells with a myxoid background.
Immunohistochemical studies classically show positive expression for brachyury, cytokeratins, and
S-1004,5,7. Brachyury, a transcription factor involved in the differentiation of the notochord, is a specific
marker for notochordal tumors that allows for the differentiation of chordomas from other mimics,
including metastatic mucinous adenocarcinomas and myoepithelial tumors.
Extra-axial chordomas can also share common features with cartilage tumors. As such, they are often
overlooked on initial presentation until other more common tumors have been entertained. Here, we
describe a rare case of a 30-year-old female who presented with an extra-axial chordoma in the left distal
femur metaphysis after a long clinical course of left knee pain.

CASE REPORT

A 30-year-old female with a four-year history of worsening intermittent anteromedial left knee pain
presented for an initial orthopedic consultation. On this first visit, the patient reported that the pain had
become more constant, often worse following activity. Physical exam did not show any swelling, skin
changes, erythema, or increased warmth. She had full left knee range of motion but was moderately tender
on palpation. Her sensation, reflexes, and strength all remained within normal limits. She also denied any
https://rdw.rowan.edu/crjcsm/vol2/iss1/4
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fever, chills, night sweats, or history of trauma.
Radiographs of the knee demonstrated a lucent lesion with peripheral sclerosis, eccentrically located
within the anteromedial femoral diaphysis. The lesion was further characterized as expansile lesion
(measuring 1.5 x 1.5 x 1.1 cm) within the cortex of the anterior femur with T2 hyperintensity on magnetic
resonance imaging (MRI). When compared to imaging performed two years prior, there was a mild
interval increase in the size of the lesion, which previously measured 1.5 x 0.9 x 1.0 cm. These findings
had raised concerns for either an enchondroma or a periosteal chondroma. The patient was scheduled to
undergo a curettage, biopsy, and possible allograft.
However, the patient later cancelled the surgery and was eventually lost to follow-up. She subsequently
presented two years later with worsening intermittent left knee pain and difficulty climbing stairs. Her
physical exam remained unchanged. Repeat radiographs of the left knee showed continued interval growth
of the lesion, now measuring 1.3 x 1.9 x 2.6 cm, but with otherwise similar imaging characteristics
(Figures 1A and 1B). An MRI at the time confirmed an eccentric, cortically based lesion in the
anteromedial distal femoral metaphysis with T2 hyperintensity (Figures 2A, 2B, and 2C). The patient did
not present with any other symptoms that would warrant suspicion for metastasis or other new lesions, and
further imaging was not recommended.
The patient underwent an open biopsy of the left distal femur with curettage of the bone lesion. The
sample was sent to pathology with the final report revealing a diagnosis of extra-axial chordoma. The
tumor consisted of predominantly epithelioid cells set in an abundant myxoid matrix (Figure 3). These
cells contained hyperchromatic and pleomorphic nuclei with abundant eosinophilic and vacuolated
cytoplasm. Immunohistochemical studies showed cells that stained strongly positive for EMA, CK19,
SATB2 and brachyury. Focal expression of pancytokeratin (AE1/AE3), Cam5.2 and S100 were present as
well. Ki67 proliferation index was < 5%, consistent with a slow-growing tumor.
The pathology showed mild atypia in the stroma and an overall histology that was not overly malignant.
The decision was made to meticulously cauterize the base of the lesion at this time and to exercise
conservative management with routine clinical and radiographic surveillance. The patient presented to her
first post-op visit ten days later. Examination of the extremity revealed a well-healed incision. The patient
ambulated with normal gait using no assistive devices. She was recommended for physical therapy, which
consisted of 2-3 planned sessions a week for a total of 8 weeks. Four-month post-op visit showed that the
patient was still doing well.
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Figure 1 1A and 1B: Posterior-Anterior (PA) and Lateral radiographs of the left knee demonstrate a lucent lesion
within the anteromedial distal femoral metaphysis with a sclerotic margin and narrow zone of transition
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Figure 2 2A, 2B, 2C: Unenhanced magnetic resonance imaging of the left knee. Axial (Figure 2A) and sagittal
(Figure 2B) T2 fat saturated images as well as a sagittal T1 (Figure 2C) image demonstrate an eccentric, cortically
based soft tissue lesion (red arrow) with T2 hyperintensity and T1 hypointensity arising from the anteromedial distal
femoral metaphysis. Minimal adjacent bone marrow and soft tissue edema are seen (white arrow).
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Figure 3 H&E stains of the patient’s biopsy sample, showing clusters and cords of pleomorphic epithelioid tumor
cells set in an abundant myxoid matrix. On high power, tumor cells feature hyperchromatic and pleomorphic nuclei
and abundant eosinophilic to vacuolated cytoplasm (arrow pointing to a physaliferous cell). The tumor cells are
strongly positive for EMA and brachyury and variably positive for S100 (which highlights cytoplasmic vacuoles too,
arrows). Ki67 proliferation index is < 5%, consistent with a slow-growing tumor. The tumor cells are also positive
for CK19, cytoplasmic SATB2, variably positive for PanCK (AE1/AE3), Cam5.2, while negative for CD31, CD34,
SOX10, desmin and H3K36M (not shown).
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DISCUSSION

Extra-axial chordomas are extremely rare neoplasms that continue to be a challenging diagnosis for
clinicians. For one, they are slow-growing tumors, and patients usually present after a long clinical course,
often in their fourth to seventh decade8. The most common presentation is a slowly enlarging mass with
localized pain9. Moreover, the findings of extra-axial chordomas often resemble those of
well-differentiated cartilage tumors, such as an enchondroma, chondrosarcoma, or even synovial
osteochondromatosis5. Their similarities can be attributed to their common notochord origin. However,
cartilage tumors are by far much more common, and their diagnoses are more likely to be considered first,
as was the case with our patient10.
Imaging is the next step in the clinical assessment of these tumors, even though radiological findings often
show much overlap between extra-axial and axial chordomas5. Radiographs demonstrate that chordomas
are lytic and well-defined lesions with sclerotic margins4,7,11. There may also be an associated soft tissue
mass and cortical permeation. On further evaluation with CT, chordomas classically are seen as
circumscribed, hypoattenuating, expansile soft tissue masses with surrounding sclerosis or bone
destruction12. Calcifications may be present, and associated soft tissue components show moderate to
significant enhancement on contrast enhanced CT 2 . MRI, however, is superior for tumor characterization
and evaluation of disease extent. On T1-weighted sequences, chordomas demonstrate variable signal
intensity, with most cases exhibiting low-to-moderate signal4. Small foci of hyper-intensity may be
present, indicating underlying mucus or hemorrhage. On T2-weighted imaging, chordomas are classically
hyperintense with possible heterogenous areas of hypointensity secondary to mucus or hemorrhage4,5,12.
Enhancement is seen on post-contrast imaging. Unfortunately, these imaging features are non-specific and
are similarly seen with cartilaginous tumors, making the diagnosis by radiologic findings alone difficult.
Final diagnosis relies on careful histologic assessment assisted with the use of an array of
immunohistochemical stains. Clinicians can use these markers in combination with radiographic evidence
to diagnose chordoma with high confidence. Nuclear expression of the brachyury transcription factor is
highly characteristic of chordomas11,13. Brachyury is a member of the T-box proteins that is highly
sensitive and specific for early notochord differentiation5. Clinicians can use this finding to help
distinguish skeletal and soft tissue extra-axial chordomas from other mimics and to establish a diagnosis.
Other important positive markers include cytokeratins AE1/AE3, vimentin, S-100 protein, and epithelial
membrane antigen (EMA), which can also add another degree of confidence in ruling out cartilage
tumors.11,12.
There is also the very rare challenge of differentiating extra-axial chordomas and metastasis from axial
chordomas. While chordomas are known for their local aggressiveness and recurrence, metastatic disease
Published by Rowan Digital Works, 2020
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has been reported in up to 10% of cases, with the most common site being the lungs9. There is some
evidence in the literature that FDG PET/CT can help make the distinction between extra-axial versus
metastatic axial disease. It has been reported that FDG PET/CT usually demonstrates increased uptake of
FDG in axial chordomas2,8.
Extra-axial chordomas account for 6% of all chordomas, and their extreme rarity makes it a challenging
diagnosis for clinicians and radiologists1. They can present atypically and in an indolent manner and are
often misdiagnosed as chondrosarcomas or myoepitheliomas. To date, there have been 28 cases of
extra-axial chordoma reported in the literature, but only two other cases of extra-axial chordoma of the
femur4. Our presented case adds to the knowledge base of extra-axial chordomas, with emphasis on their
histology, immuno-histochemical staining patterns as well as radiologic features. Clinicians can be better
equipped to recognize extra-axial chordomas as a potential early diagnosis in the context of someone
presenting with a long history of intermittent and worsening knee pain.
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